Back to today’s briefing

Story perspectives

Massachusetts Women Sue Novo Nordisk Over Vision Loss Claims

6/20/2025

50 11

Summary

Story summary

Two Massachusetts women are taking a stand against Novo Nordisk, filing federal lawsuits after claiming that the weight-loss drug Wegovy led to irreversible vision loss from Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). They allege the company neglected to disclose these serious risks while promoting the drug, seeking compensation for their suffering and emotional turmoil.

1 of 1

Story summary

Two Massachusetts women are taking a stand against Novo Nordisk, filing federal lawsuits after claiming that the weight-loss drug Wegovy led to irreversible vision loss from Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). They allege the company neglected to disclose these serious risks while promoting the drug, seeking compensation for their suffering and emotional turmoil.